Trodelvy (Sacituzumab Govitecan) in India: A Sourcing Guide for Hospitals Treating Triple-Negative Breast Cancer

Trodelvy has become an increasingly requested medicine among Indian oncology centres treating triple-negative breast cancer, a subtype known for its aggressive course and historically limited treatment options. As demand for this antibody-drug conjugate grows, hospital procurement teams and pharmacies are asking more practical questions — less about the science, which is well established in oncology […]